Release – Euroseas Ltd. Announces a Two-to-Three Month $130000 per day Charter for its MV Synergy Oakland


Euroseas Ltd. Announces a Two-to-Three Month $130,000 per day Charter for its M/V “Synergy Oakland” Followed by a Minimum Four-Year Charter at $42,000 per day

 

ATHENS, Greece, Nov. 29, 2021 (GLOBE NEWSWIRE) — Euroseas Ltd. (NASDAQ: ESEA, the “Company” or “Euroseas”), an owner and operator of container carrier vessels and provider of seaborne transportation for containerized cargoes, announced today two new consecutive time charter contracts for its container vessel M/V “Synergy Oakland”, a 4,253 TEU vessel built in 2009.

Specifically:

  1. a new time charter contract for a period of between two and three months at a daily rate of $130,000, commencing between January 5th and January 25th when the vessel will be redelivered from its current charterer; and,
  2. immediately following the completion of the above charter, a new time charter contract for a period of a minimum of forty-eight and a maximum of fifty-one months at the option of the charterer at a daily rate of $42,000, commencing the latest by April 15th when the vessel will be redelivered from its previous charterer.

Aristides Pittas, Chairman and CEO of Euroseas commented“We are very pleased to announce very profitable new charters for one of our vessels, our M/V “Synergy Oakland”, that capture both the exceptional strength of the current short-term market over the next two to three months and also provide secured employment for a minimum of an additional four years. As a result of these charters, M/V “Synergy Oakland” is expected to make an EBITDA contribution of about $11.5 million during the first quarter of 2022 and about $12 million per year during each of the next four years, totaling about $57 million of EBITDA contribution, or about $7.80 per share, over the duration of its new charters.

“Both the rates and the duration of the above charters are indicative of the strength and recovery of the market from a slight correction we had experienced over the past month. We expect to be able to continue benefitting from the present market as there are another four of our vessels in our fleet which open for re-chartering within the next four months and another two vessels later within 2022. If the present market levels continue, renewals of expiring charters should result in significant further increases in our profitability and employment coverage for the following years, providing a solid liquidity foundation for further growth of our company and rewards to our shareholders as our Board or Directors sees fit.”

Fleet Profile:

After the new charters of M/V “Synergy Oakland”, the Euroseas Ltd. fleet and employment profile will be as follows:

Name Type Dwt TEU Year
Built
Employment(*) TCE Rate
($/day)
Container Carriers            
LEO PARAMOUNT (to be renamed MARCOS V) Intermediate 72,968 6,350 2005 TC until Dec-24
plus 12 months option
$42,200
option $15,000
AKINADA BRIDGE(*) Intermediate 71,366 5,610 2001 TC until Oct-22 $20,000
SYNERGY BUSAN(*) Intermediate 50,726 4,253 2009 TC until Aug-24 $25,000
SYNERGY ANTWERP(*) Intermediate 50,726 4,253 2008 TC until Sep-23 $18,000
SYNERGY OAKLAND(*) Intermediate 50,787 4,253 2009 TC until Jan-21
then until Mar-22
then until Mar-26
$202,000
$130,000
$42,000
SYNERGY KEELUNG (+) Intermediate 50,969 4,253 2009 TC until Jun-22
plus 8-12 months
option
$11,750;
option $14,500
EM KEA (*) Feeder 42,165 3,100 2007 TC until May-23 $22,000
EM ASTORIA (+) Feeder 35,600 2,788 2004 TC until Feb-22 $18,650
EM CORFU(+) Feeder 34,654 2,556 2001 TC until Nov-21
then repositioning
trip to drydock
$10,200
$5,125 for up to 37
days ($35,000 if
more than 37
days)
EVRIDIKI G (+) Feeder 34,677 2,556 2001 TC until Jan-22 $15,500
DIAMANTIS P. (*) Feeder 30,360 2,008 1998 TC until Oct-24 $27,000
EM SPETSES(*)

Feeder
23,224 1,740 2007 TC until Aug-24 $29,500
JONATHAN P(*) Feeder 23,351 1,740 2006 TC until Sep-24 $26,662(**)
EM HYDRA(*) Feeder 23,351 1,740 2005 TC until Apr-23 $20,000
JOANNA(*) Feeder 22,301 1,732 1999 TC until Oct-22 $16,800
AEGEAN  EXPRESS(*) Feeder 18,581 1,439 1997 TC until Mar-22 $11,500
Total Container Carriers 16 635,806 50,371      


Vessels under construction Type Dwt TEU To be delivered
H4201 Feeder 37,237 2,800 Q1 2023
H4202 Feeder 37,237 2,800 Q2 2023

Notes:  
(*) TC denotes time charter. Charter duration indicates the earliest redelivery date; all dates listed are the earliest redelivery dates under each TC unless the contract rate is lower than the current market rate in which cases the latest redelivery date is assumed; vessels with the latest redelivery date shown are marked by (+).
(**) Rate is net of commissions (which are typically 5-6.25%)

About Euroseas Ltd.
Euroseas Ltd. was formed on May 5, 2005 under the laws of the Republic of the Marshall Islands to consolidate the ship owning interests of the Pittas family of Athens, Greece, which has been in the shipping business over the past 140 years. Euroseas trades on the NASDAQ Capital Market under the ticker ESEA. 

Euroseas operates in the container shipping market. Euroseas’ operations are managed by Eurobulk Ltd., an ISO 9001:2008 and ISO 14001:2004 certified affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. Euroseas employs its vessels on spot and period charters and through pool arrangements. 

After the delivery of M/V Leo Paramount, the Company will have a fleet of 16 vessels comprising of 10 Feeder and 6 Intermediate containerships. Euroseas 16 containerships have a cargo capacity of 50,371 teu. Furthermore, after the delivery of two feeder containership newbuildings in the first half of 2023, Euroseas’ fleet will consist of 18 vessels with a total carrying capacity of 55,971 teu.

Forward Looking Statement
This press release contains forward-looking statements (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) concerning future events and the Company’s growth strategy and measures to implement such strategy; including expected vessel acquisitions and entering into further time charters. Words such as “expects,” “intends,” “plans,” “believes,” “anticipates,” “hopes,” “estimates,” and variations of such words and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct. These statements involve known and unknown risks and are based upon a number of assumptions and estimates that are inherently subject to significant uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to changes in the demand for containerships, competitive factors in the market in which the Company operates; risks associated with operations outside the United States; and other factors listed from time to time in the Company’s filings with the Securities and Exchange Commission. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based. 

Visit our website www.euroseas.gr

Company Contact Investor Relations / Financial Media
Tasos Aslidis Nicolas Bornozis
Chief Financial Officer President
Euroseas Ltd. Capital Link, Inc.
11 Canterbury Lane, 230 Park Avenue, Suite 1536
Watchung, NJ 07069 New York, NY 10169
Tel. (908) 301-9091 Tel. (212) 661-7566
E-mail: aha@euroseas.gr E-mail: nbornozis@capitallink.com

Release – Ceapro Inc. Announces R D Funding to Support PGX Technology Project


Ceapro Inc. Announces R&D Funding to Support PGX Technology Project

 

– PGX Technology further recognized as a disruptive technology

– Additional support paves the way for the manufacturing of pharmaceutical-grade yeast beta glucan (YBG)

EDMONTON, Alberta, Nov. 29, 2021 (GLOBE NEWSWIRE) — Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced they are receiving advisory services and up to $480,000 in funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to support Ceapro’s project entitled, “Boosting innovation capacity of Pressurized Gas eXpanded Technology (PGX) towards pharmaceutical applications.”

This project follows previous work supported by NRC IRAP where Ceapro successfully upgraded its Edmonton-based demonstration PGX plant and developed several biopolymer blends like alginate-yeast beta glucan-CoQ10 as well as a pure powder formulation of yeast beta glucan, which is now being studied as a potential inhalable therapeutic for fibrotic lung diseases including COVID-19 conditions.

This additional support from NRC IRAP will allow Ceapro to further develop the patented PGX Technology to increase its innovation capacity by designing the first pharmaceutical PGX processing unit along with bioactive impregnation and loading units. These new units will be used to generate active pharmaceutical ingredients like yeast beta glucan needed for stability studies and clinical human trials required to confirm its immune-boosting benefits while also tackling post-COVID-19 conditions such as pain, depression, sleep disorders, anxiety, and lung fibrosis.

“We are very grateful to NRC IRAP for their unwavering support,” said Gilles Gagnon, M.Sc., MBA, President and CEO of Ceapro. “In line with our stated strategy to expand our business model towards becoming a high-end Life Science company, this support will allow Ceapro to design and initiate the construction of the first pharmaceutical-grade PGX system that we believe will produce tomorrow’s active pharmaceutical ingredients.”

About Pressurized Gas eXpanded Liquid Technology (PGX)

Ceapro’s patented Pressurized Gas eXpanded (PGX) technology is a unique and disruptive technology with several key advantages over conventional drying and purification technologies that can be used to process biopolymers into high-value, fine-structured, open-porous polymer structures and novel biocomposites. PGX is ideally suited for processing challenging high-molecular-weight, water-soluble biopolymers. It has the ability to make ultra-light, highly porous polymer structures on a continuous basis, which is not possible using today’s conventional technologies. PGX was invented by Dr. Feral Temelli from the Department of Agricultural, Food & Nutritional Science of the University of Alberta (U of A) along with Dr. Bernhard Seifried, now Senior Director of Engineering Research and Technology at Ceapro. The license from U of A provides Ceapro with exclusive worldwide rights in all industrial applications.

About Ceapro Inc.

Ceapro Inc. is a Canadian biotechnology company involved in the development of proprietary extraction technology and the application of this technology to the production of extracts and “active ingredients” from oats and other renewable plant resources. Ceapro adds further value to its extracts by supporting their use in cosmeceutical, nutraceutical, and therapeutics products for humans and animals. The Company has a broad range of expertise in natural product chemistry, microbiology, biochemistry, immunology and process engineering. These skills merge in the fields of active ingredients, biopharmaceuticals and drug-delivery solutions. For more information on Ceapro, please visit the Company’s website at www.ceapro.com.

For more information contact:

Jenene Thomas
JTC Team, LLC
Investor Relations and Corporate Communications Advisor
T (US): +1 (833) 475-8247
E: czo@jtcir.com

This press release does not express or imply that the Company claims its product has the ability to eliminate, cure or contain the SARS-2-CoV-2 (COVID-19) at this time.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release

Source: Ceapro Inc.

Ceapro Inc. Announces R&D Funding to Support PGX Technology Project


Ceapro Inc. Announces R&D Funding to Support PGX Technology Project

 

– PGX Technology further recognized as a disruptive technology

– Additional support paves the way for the manufacturing of pharmaceutical-grade yeast beta glucan (YBG)

EDMONTON, Alberta, Nov. 29, 2021 (GLOBE NEWSWIRE) — Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced they are receiving advisory services and up to $480,000 in funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to support Ceapro’s project entitled, “Boosting innovation capacity of Pressurized Gas eXpanded Technology (PGX) towards pharmaceutical applications.”

This project follows previous work supported by NRC IRAP where Ceapro successfully upgraded its Edmonton-based demonstration PGX plant and developed several biopolymer blends like alginate-yeast beta glucan-CoQ10 as well as a pure powder formulation of yeast beta glucan, which is now being studied as a potential inhalable therapeutic for fibrotic lung diseases including COVID-19 conditions.

This additional support from NRC IRAP will allow Ceapro to further develop the patented PGX Technology to increase its innovation capacity by designing the first pharmaceutical PGX processing unit along with bioactive impregnation and loading units. These new units will be used to generate active pharmaceutical ingredients like yeast beta glucan needed for stability studies and clinical human trials required to confirm its immune-boosting benefits while also tackling post-COVID-19 conditions such as pain, depression, sleep disorders, anxiety, and lung fibrosis.

“We are very grateful to NRC IRAP for their unwavering support,” said Gilles Gagnon, M.Sc., MBA, President and CEO of Ceapro. “In line with our stated strategy to expand our business model towards becoming a high-end Life Science company, this support will allow Ceapro to design and initiate the construction of the first pharmaceutical-grade PGX system that we believe will produce tomorrow’s active pharmaceutical ingredients.”

About Pressurized Gas eXpanded Liquid Technology (PGX)

Ceapro’s patented Pressurized Gas eXpanded (PGX) technology is a unique and disruptive technology with several key advantages over conventional drying and purification technologies that can be used to process biopolymers into high-value, fine-structured, open-porous polymer structures and novel biocomposites. PGX is ideally suited for processing challenging high-molecular-weight, water-soluble biopolymers. It has the ability to make ultra-light, highly porous polymer structures on a continuous basis, which is not possible using today’s conventional technologies. PGX was invented by Dr. Feral Temelli from the Department of Agricultural, Food & Nutritional Science of the University of Alberta (U of A) along with Dr. Bernhard Seifried, now Senior Director of Engineering Research and Technology at Ceapro. The license from U of A provides Ceapro with exclusive worldwide rights in all industrial applications.

About Ceapro Inc.

Ceapro Inc. is a Canadian biotechnology company involved in the development of proprietary extraction technology and the application of this technology to the production of extracts and “active ingredients” from oats and other renewable plant resources. Ceapro adds further value to its extracts by supporting their use in cosmeceutical, nutraceutical, and therapeutics products for humans and animals. The Company has a broad range of expertise in natural product chemistry, microbiology, biochemistry, immunology and process engineering. These skills merge in the fields of active ingredients, biopharmaceuticals and drug-delivery solutions. For more information on Ceapro, please visit the Company’s website at www.ceapro.com.

For more information contact:

Jenene Thomas
JTC Team, LLC
Investor Relations and Corporate Communications Advisor
T (US): +1 (833) 475-8247
E: czo@jtcir.com

This press release does not express or imply that the Company claims its product has the ability to eliminate, cure or contain the SARS-2-CoV-2 (COVID-19) at this time.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release

Source: Ceapro Inc.

Great Bear Resources (GTBAF)(GBR:CA) – Discovery of New Gold Zone Underscores Dixie’s Growing Resource Potential

Monday, November 29, 2021

Great Bear Resources (GTBAF)(GBR:CA)
Discovery of New Gold Zone Underscores Dixie’s Growing Resource Potential

Noble Capital Markets research on Great Bear Resources is published under ticker symbols GTBAF and GBR:CA. The price target is in USD and based on ticker symbol GTBAF. Great Bear Resources Ltd is a gold exploration company. It explores for mineral properties in the Red Lake District in Ontario, Canada. Its property portfolio includes Great Bear’s Red Lake Properties with the flagship Dixie project, Pakwash property, and Sobel property.

Mark Reichman, Senior Research Analyst of Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    LP Fault drilling continues at depth. LP Fault drilling continues to expand gold mineralization, including at depth. Drilling has targeted various points along 2.9 kilometers of strike length, between surface and ~600 meters depth. Results have been uniformly good. For example, Hole BR-407 returned 1.83 grams of gold per tonne over 91.35 meters from 430.40 to 521.75 meters depth, including 11.29 grams of gold per tonne over 3.00 meters. Hole Br-426 intersected gold assaying 3.10 grams of gold per tonne over 28.30 meters, including 16.07 grams of gold per tonne over 3.70 meters.

    Discovery of new high-grade gold zone.  Great Bear Resources recently resumed drilling near the Hinge and Limb zones and discovered a new high-grade gold zone. The “Midwest” zone is located 275 meters northwest of the Hinge zone and 250 meters south of the Dixie Limb zone. Previous holes drilled at the Limb zone did not penetrate far enough to the west to intersect the Midwest zone. Hole DL-071 …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Release – Kratos Receives $4.1 Million Unmanned Aerial Vehicle System Award from International Customer


Kratos Receives $4.1 Million Unmanned Aerial Vehicle System Award from International Customer

 

SAN DIEGO
Nov. 29, 2021 (GLOBE NEWSWIRE) — 
Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a leading National Security Solutions provider, announced today that its Kratos Unmanned Systems Division (KUSD) has recently received a 
$4.1 million contract award from an international customer for high performance, unmanned aerial target drone system aircraft and related services. KUSD is a recognized industry leader in the design and production of affordable, high performance, jet powered, unmanned aerial aircraft and systems for threat representative target drones and tactical applications. Work under this contract award will be performed at secure Kratos manufacturing facilities and at customer locations. Due to competitive, security related, and other considerations, no additional information will be provided related to this contract award.

Steve Fendley, President of KUSD, said, “The recapitalization of strategic weapon systems by 
the United States and its allies is driving significant global demand for Kratos target drone systems, which represent certain leading technology system and platform threats of our peer adversaries.  At Kratos, affordability is a technology, and our high performance target and tactical drone systems are representative of our affordability mission. The broad application set of these drone systems as well as the speed at which they can be developed, produced, modified, and reconfigured creates the high utility / affordable cost ratio, especially as compared to manned systems. The capabilities and performance per cost ratio is highly recognized and appreciated by our established and growing customer base.”

About Kratos Defense & Security Solutions

Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS) develops and fields transformative, affordable technology, platforms and systems for United States National Security related customers, allies and commercial enterprises. Kratos is changing the way breakthrough technology for these industries are rapidly brought to market through proven commercial and venture capital backed approaches, including proactive research and streamlined development processes. At Kratos, affordability is a technology, and we specialize in unmanned systems, satellite communications, cyber security/warfare, microwave electronics, missile defense, hypersonic systems, training, combat systems and next generation turbo jet and turbo fan engine development. For more information, please visit www.KratosDefense.com.

Notice Regarding Forward-Looking Statements
Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Kratos and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Kratos undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Kratos believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Kratos in general, see the risk disclosures in the Annual Report on Form 10-K of Kratos for the year ended December 27, 2020, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the SEC by Kratos.

Press Contact:
Yolanda White
858-812-7302 Direct

Investor Information:
877-934-4687
investor@kratosdefense.com

Source: Kratos Defense & Security Solutions, Inc.

Ocugen (OCGN) – Start of COVAXIN Clinical Trial Delayed by FDA Hold

Monday, November 29, 2021

Ocugen (OCGN)
Start of COVAXIN Clinical Trial Delayed by FDA Hold

Ocugen Inc is a clinical stage biopharmaceutical company. It is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. Ocugen offers a diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules and targets a broad range of high-need retinal and ocular surface diseases.

Robert LeBoyer, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Clinical Hold Delays Trial.  Ocugen announced that the FDA has issued a Clinical Hold for its Investigational New Drug Application for COVAXIN, its vaccine for protection from COVID-19. The IND delays the start of a bridging study designed to verify that the immune response in the US population is comparable to the Phase 3 study population. This Phase 3 data was submitted for marketing approval.

    Reason For The Hold Were Not Specified.  Ocugen announced the IND submission on October 27, and began preparing for the clinical study. An IND becomes effective unless the FDA responds with questions or rejection within 30 days. The notification to Ocugen comes at the end of this 30-day period, but no reasons were provided. Based on previous cases, we believe the FDA could be taking extra …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Kratos Receives $4.1 Million Unmanned Aerial Vehicle System Award from International Customer


Kratos Receives $4.1 Million Unmanned Aerial Vehicle System Award from International Customer

 

SAN DIEGO
Nov. 29, 2021 (GLOBE NEWSWIRE) — 
Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a leading National Security Solutions provider, announced today that its Kratos Unmanned Systems Division (KUSD) has recently received a 
$4.1 million contract award from an international customer for high performance, unmanned aerial target drone system aircraft and related services. KUSD is a recognized industry leader in the design and production of affordable, high performance, jet powered, unmanned aerial aircraft and systems for threat representative target drones and tactical applications. Work under this contract award will be performed at secure Kratos manufacturing facilities and at customer locations. Due to competitive, security related, and other considerations, no additional information will be provided related to this contract award.

Steve Fendley, President of KUSD, said, “The recapitalization of strategic weapon systems by 
the United States and its allies is driving significant global demand for Kratos target drone systems, which represent certain leading technology system and platform threats of our peer adversaries.  At Kratos, affordability is a technology, and our high performance target and tactical drone systems are representative of our affordability mission. The broad application set of these drone systems as well as the speed at which they can be developed, produced, modified, and reconfigured creates the high utility / affordable cost ratio, especially as compared to manned systems. The capabilities and performance per cost ratio is highly recognized and appreciated by our established and growing customer base.”

About Kratos Defense & Security Solutions

Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS) develops and fields transformative, affordable technology, platforms and systems for United States National Security related customers, allies and commercial enterprises. Kratos is changing the way breakthrough technology for these industries are rapidly brought to market through proven commercial and venture capital backed approaches, including proactive research and streamlined development processes. At Kratos, affordability is a technology, and we specialize in unmanned systems, satellite communications, cyber security/warfare, microwave electronics, missile defense, hypersonic systems, training, combat systems and next generation turbo jet and turbo fan engine development. For more information, please visit www.KratosDefense.com.

Notice Regarding Forward-Looking Statements
Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Kratos and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Kratos undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Kratos believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Kratos in general, see the risk disclosures in the Annual Report on Form 10-K of Kratos for the year ended December 27, 2020, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the SEC by Kratos.

Press Contact:
Yolanda White
858-812-7302 Direct

Investor Information:
877-934-4687
investor@kratosdefense.com

Source: Kratos Defense & Security Solutions, Inc.

FAT Brands Inc. (FAT) – Another Order of Chicken Wings

Monday, November 29, 2021

FAT Brands Inc. (FAT)
Another Order of Chicken Wings

FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, and acquires predominantly fast casual restaurant concepts. The company provides turkey burgers, chicken Sandwiches, chicken tenders, burgers, ribs, wrap sandwiches, and others. Its brand portfolio comprises Fatburger, Buffalo’s Cafe and Express, and Ponderosa and Bonanza. The company’s overall footprint covers nearly 32 countries. Fatburger generates maximum revenue for the company.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Another Acquisition. FAT Brands announced an agreement to acquire Native Grill & Wings, an Arizona-based restaurant chain known for its cult-like following and 20 wing flavors that guests can order by the individual wing, for $20 million. The acquisition will be funded with cash from the issuance of new notes from the Company’s securitization facilities and is expected to close in mid-December 2021. The business is expected to increase the Company’s post-COVID normalized EBITDA by approximately $3 million in 2022.

    Native Grill & Wings.  Based in Chandler, Arizona, Native Grill & Wings is a family-friendly, polished sports grill with 23 franchised locations throughout Arizona, Illinois, and Texas. Native Grill will complement Fat Brands’ existing wing concepts, Buffalo’s and Hurricanes, in our view …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Aurania Resources (AUIAF)(ARU:CA) – Focused on Discovery: Highlights from Aurania Resources Investor Webinar

Monday, November 29, 2021

Aurania Resources (AUIAF)(ARU:CA)
Focused on Discovery: Highlights from Aurania Resources Investor Webinar

As of April 24, 2020, Noble Capital Markets research on Aurania Resources is published under ticker symbols (AUIAF and ARU:CA). The price target is in USD and based on ticker symbol AUIAF. Research reports dated prior to April 24, 2020 may not follow these guidelines and could account for a variance in the price target.

Aurania Resources Ltd. is a Canada-based junior mining exploration company engaged in the identification, evaluation, acquisition, and exploration of mineral property interests, with a focus on precious metals and copper. Its flagship asset, The Lost Cities-Cutucu Project, is in southeastern Ecuador in the Province of Morona-Santiago. The company also has several minor projects in Switzerland.

Mark Reichman, Senior Research Analyst of Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Investor webinar. Investor webinar. Aurania recently hosted a webinar for investors and discussed its current drill program and exploration strategy. The company completed Hole 4 at the Tiria-Shimpia silver-zinc target and is awaiting drill results in December before deciding whether to drill a fifth hole. Another rig at the Tsenken N1 copper-silver target just started on Hole 9. While sequencing is fluid, it appears the intrusive-related Awacha and Tatasham copper-gold porphyry targets are next in line, respectively, followed by the Latorre C epithermal gold-silver target.

    Updating estimates.  Aurania does not generate revenue as an exploration company and incurs expenses to advance its projects. Third quarter expenses were higher than our estimate, largely due to greater exploration expense. While we have increased our 2021 loss per share estimate to $(0.53) from $(0.47), we are reducing our 2022 loss per share estimate to $(0.25) from $(0.47) due, in part, to lower …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Aurania Resources (AUIAF)(ARU:CA) – Focused on Discovery Highlights from Aurania Resources Investor Webinar

Monday, November 29, 2021

Aurania Resources (AUIAF)(ARU:CA)
Focused on Discovery: Highlights from Aurania Resources Investor Webinar

As of April 24, 2020, Noble Capital Markets research on Aurania Resources is published under ticker symbols (AUIAF and ARU:CA). The price target is in USD and based on ticker symbol AUIAF. Research reports dated prior to April 24, 2020 may not follow these guidelines and could account for a variance in the price target.

Aurania Resources Ltd. is a Canada-based junior mining exploration company engaged in the identification, evaluation, acquisition, and exploration of mineral property interests, with a focus on precious metals and copper. Its flagship asset, The Lost Cities-Cutucu Project, is in southeastern Ecuador in the Province of Morona-Santiago. The company also has several minor projects in Switzerland.

Mark Reichman, Senior Research Analyst of Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Investor webinar. Investor webinar. Aurania recently hosted a webinar for investors and discussed its current drill program and exploration strategy. The company completed Hole 4 at the Tiria-Shimpia silver-zinc target and is awaiting drill results in December before deciding whether to drill a fifth hole. Another rig at the Tsenken N1 copper-silver target just started on Hole 9. While sequencing is fluid, it appears the intrusive-related Awacha and Tatasham copper-gold porphyry targets are next in line, respectively, followed by the Latorre C epithermal gold-silver target.

    Updating estimates.  Aurania does not generate revenue as an exploration company and incurs expenses to advance its projects. Third quarter expenses were higher than our estimate, largely due to greater exploration expense. While we have increased our 2021 loss per share estimate to $(0.53) from $(0.47), we are reducing our 2022 loss per share estimate to $(0.25) from $(0.47) due, in part, to lower …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

QuickChek – November 29, 2021



Euroseas Ltd. Announces a Two-to-Three Month $130,000 per day Charter for its M/V “Synergy Oakland” Followed by a Minimum Four-Year Charter at $42,000 per day

Euroseas Ltd announced two new consecutive time charter contracts for its container vessel M/V “Synergy Oakland”, a 4,253 TEU vessel built in 2009

Research, News & Market Data on Euroseas

Watch recent presentation from Euroseas



Ceapro Inc. Announces R&D Funding to Support PGX Technology Project

Ceapro Inc announced they are receiving advisory services and up to $480,000 in funding from the National Research Council of Canada Industrial Research Assistance Program

Research, News & Market Data on Ceapro



Kratos Receives $4.1 Million Unmanned Aerial Vehicle System Award from International Customer

Kratos Defense & Security Solutions announced that its Kratos Unmanned Systems Division (KUSD) has recently received a $4.1 million contract award from an international customer for high performance, unmanned aerial target drone system aircraft and related services

Research, News & Market Data on Kratos



Capstone Green Energy (NASDAQ:CGRN) Partners With PowerTap (OTC:MOTNF) On Strategic Licensing and Manufacturing Agreement

Capstone Green Energy announced that it has entered into a strategic licensing and manufacturing agreement with PowerTap Hydrogen Capital Corporation

Research, News & Market Data on Capstone Green Energy

Watch recent presentation from Capstone Green Energy

 

Stay up to date. Follow us:

 

Protein Infused Chewing Gum Could Cut Spread of Covid 19 and Variants


Image Credit: Marco Verch (Flickr)

Could a Chewing Gum Reduce COVID-19’s Spread? Here’s What We Need to Know First

 

An experimental chewing gum could reduce the spread of Sars-CoV-2, the virus that causes COVID-19, according to a recent study published in the journal Molecular Therapy. You might already have noticed headlines calling the findings “fresh hope” in our fight against COVID-19. But how excited should we be? And could this gum work against Omicron, the newest variant of concern?

Evidence shows people infected with Sars-CoV-2 have high levels of virus in their saliva. So researchers in the US wanted to investigate whether a specially designed chewing gum could reduce the amount of virus in the mouth, and therefore potentially reduce its spread.

Chewing gum to promote oral health is not a new idea. Studies have shown that chewing gums containing certain substances such as calcium and bicarbonate can improve oral health, reducing the incidence of dental ailments and cutting the numbers of harmful bacteria. But specifically targeting a virus in this way is a novel approach.

Sars-CoV-2 gains entry into human cells by latching onto ACE2 proteins, which are found on the surfaces of certain cells in our body. The researchers produced a gum containing high levels of ACE2 proteins, produced in plants, with the idea being that the ACE2 proteins in the chewing gum could “trap” virus particles in the mouth, minimizing the opportunity they have to infect our cells and spread to other people.

 

 

To test the effectiveness of the chewing gum, the researchers took saliva samples from patients with COVID-19 and mixed these samples with a powdered form of the gum. They found the treated saliva had significantly reduced numbers of Sars-CoV-2 virus particles compared to those treated with a placebo (the same gum but without the ACE2 protein).

The researchers also demonstrated that the gum prevented a pseudotyped virus (a harmless virus with the Sars-CoV-2 spike protein on its surface) from infecting cells in the lab. As little as 5mg of the gum was associated with significantly reduced viral entry into cells, while 50mg of the gum reduced viral entry by 95%. This suggests the ACE2 gum severely hinders the ability of the Sars-CoV-2 spike protein to infect cells.

Reasons for Caution

Although these results seem promising, there are a number of reasons we can’t view this gum as a pandemic gamechanger just yet. First, this is early-stage research, meaning the experiments were conducted in a lab in controlled conditions rather than with real people.

The conditions in a lab experiment are going to be different to the conditions in a person’s mouth. While the researchers used a chewing simulator machine to show that the motion of chewing doesn’t affect the integrity of the ACE2 protein in the gum, there are other questions for which we don’t yet have answers.

For example, would the environment in a person’s mouth, such as body temperature and oral bacteria, impact the effectiveness of the gum? And how long would one piece of gum continue working for? It will be interesting to see whether the gum produces similar effects in people as it has in the lab if the research progresses to this stage.

 

 

Second, although the gum significantly reduced infection of a virus that carried the Sars-CoV-2 spike, the researchers didn’t use the full Sars-CoV-2 virus in their experiments. While the method they used, virus pseudotyping, is a tried and tested scientific method to assess virus entry into cells, it would be interesting to see how the gum affects the full Sars-CoV-2 virus.

As for whether the gum would be effective across different COVID variants, such as Omicron, the principles of virology give us reason to be optimistic. Regardless of the variant and its mutations, Sars-CoV-2 gains entry into human cells by latching on to ACE2 proteins – which is key to how the gum works. That said, this is another question we won’t know the answer to for sure until the product is tested in real-world trials.

Finally, it’s important to understand what this gum is designed for. The researchers point out that its main use is likely to be reducing viral spread from people with COVID-19 to others, particularly in clinical settings. It’s unclear how well it would work as a prophylactic to prevent uninfected people getting the virus, particularly when Sars-CoV-2 can be transmitted through multiple routes including the eyes and nose as well as the mouth.

All the same, this gum could have exciting prospects in a clinical setting – for example reducing spread in dental surgeries or COVID hospital wards. When used in combination with current methods such as mask wearing, ventilation and vaccination, it could be another weapon in our arsenal for preventing the spread of COVID-19. But further research is needed before we can expect to be chewing it.

 

This article was republished with permission from The Conversation, a news site dedicated to sharing ideas from academic experts.  It was written by and represents the research-based opinions of Grace C Roberts, Research Fellow in Virology, University of Leeds.

 

Suggested Reading:



Scientists Now Better Understand Viral Mutations



Tracing the Origins of a Virus





Can the Fed Stop Inflation?



The Detrimental Impact of Fed Policy on Savers

 

 

 

Stay up to date. Follow us:

 

Great Bear Resources (GTBAF)(GBR:CA) – Discovery of New Gold Zone Underscores Dixies Growing Resource Potential

Monday, November 29, 2021

Great Bear Resources (GTBAF)(GBR:CA)
Discovery of New Gold Zone Underscores Dixie’s Growing Resource Potential

Noble Capital Markets research on Great Bear Resources is published under ticker symbols GTBAF and GBR:CA. The price target is in USD and based on ticker symbol GTBAF. Great Bear Resources Ltd is a gold exploration company. It explores for mineral properties in the Red Lake District in Ontario, Canada. Its property portfolio includes Great Bear’s Red Lake Properties with the flagship Dixie project, Pakwash property, and Sobel property.

Mark Reichman, Senior Research Analyst of Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    LP Fault drilling continues at depth. LP Fault drilling continues to expand gold mineralization, including at depth. Drilling has targeted various points along 2.9 kilometers of strike length, between surface and ~600 meters depth. Results have been uniformly good. For example, Hole BR-407 returned 1.83 grams of gold per tonne over 91.35 meters from 430.40 to 521.75 meters depth, including 11.29 grams of gold per tonne over 3.00 meters. Hole Br-426 intersected gold assaying 3.10 grams of gold per tonne over 28.30 meters, including 16.07 grams of gold per tonne over 3.70 meters.

    Discovery of new high-grade gold zone.  Great Bear Resources recently resumed drilling near the Hinge and Limb zones and discovered a new high-grade gold zone. The “Midwest” zone is located 275 meters northwest of the Hinge zone and 250 meters south of the Dixie Limb zone. Previous holes drilled at the Limb zone did not penetrate far enough to the west to intersect the Midwest zone. Hole DL-071 …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision.